Company

Hemagen Diagnostics, Inc.

Headquarters: Columbia, MD, United States

Employees: 15

CEO: Mr. William P. Hales

OTC: HMGN

Detailed Description

Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Hemagen Diagnostics, Inc. has the following listings and related stock indices.


Stock: OTC: HMGN wb_incandescent

Details

Headquarters:

9033 Red Branch Road

Columbia, MD 21045

United States

Phone: 443-367-5500

Fax: 443-367-5527